Perbedaan Diagnos Laboratorium Utama Tbk. dan Lenox Pasifik Investama Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Lenox Pasifik Investama Tbk. diperdagangkan di Rp70 (kapitalisasi pasar 176 M, volume 24 jam 2,41 jt). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. lebih besar dari sisi kapitalisasi pasar, dan Lenox Pasifik Investama Tbk. lebih aktif diperdagangkan (2,41 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | LPPS | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 176 M |
Volume | 963,6 rb | 2,41 jt |
Lot | 9,64 rb | 24,14 rb |
Perputaran | 217,67 jt | 167,09 jt |
Harga Rata-rata | 225,89 | 69,23 |
Nilai Transaksi | 217,67 jt | 167,09 jt |
Harga Ekuilibrium Indikatif | 226 | 70 |
Volume Ekuilibrium Indikatif | 1 rb | 253 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.
Selengkapnya di halaman LPPS →